๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

20 recruiting trials

for Osteosarcoma in Children

Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas NCT07222735Phase 11 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: Fludarabine, Cyclophosphamide, B7-H3-CAR T Cells, Radiation Therapy Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma NCT07144254Phase 12 sites๐Ÿ“ Atlanta๐Ÿ“ Houston Emory University ยท Tests: Tegavivint, Gemcitabine Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse NCT07871864Phase 377 sites๐Ÿ“ Aarhus๐Ÿ“ Aarhus๐Ÿ“ Copenhagen Gustave Roussy, Cancer Campus, Grand Paris ยท Tests: Experimental group : Cabometyx ยฎ 40mg/m2/day (Max: 60mg/day) , Treatment schedule : Daily**, day 1-28 during 4 weeks (iโ€ฆ Study in Children and Adolescents of 177Lu-DOTATATE (Lutatheraยฎ) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site๐Ÿ“ Boadilla del Monte Fundaciรณn de investigaciรณn HM ยท Tests: Olaparib; 177Lu-DOTATATE Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method NCT07141862n/a1 site๐Ÿ“ Clermont-Ferrand University Hospital, Clermont-Ferrand ยท Tests: RT-qPCR, ddPCR Safety and Feasibility of Intraoperative Visualization With Cytalux in Children NCT06235125Phase 11 site๐Ÿ“ Chicago Ann & Robert H Lurie Children's Hospital of Chicago ยท Tests: Cytalux Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma NCT05400603Phase 11 site๐Ÿ“ Atlanta Emory University ยท Tests: Ex Vivo Expanded Allogeneic ฮณฮด T Cells in Combination with Dinutuximab, Temozolomide, Irinotecan and Zoledronate Biomarkers of Resiliency In Childhood Cancer Surgery NCT06674811n/a1 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Wearing Smartwatch, Patient Report Outcomes, Blood Draw, Clinical Data Review Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas NCT06156410Phase 14 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: Cabozantinib A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma NCT06650514Phase 21 site๐Ÿ“ Barcelona Vall d'Hebron Institute of Oncology ยท Tests: OMO-103 The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma NCT07560826Phase 29 sites๐Ÿ“ Chapel Hill๐Ÿ“ Charlotte๐Ÿ“ Charlotte Wake Forest University Health Sciences ยท Tests: High-dose Methotrexate Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma NCT04901702Phase 1, Phase 210 sites๐Ÿ“ Palo Alto๐Ÿ“ Aurora๐Ÿ“ Washington D.C. St. Jude Children's Research Hospital ยท Tests: Onivyde, Talazoparib, Temozolomide Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma NCT07428993Phase 21 site๐Ÿ“ Memphis St. Jude Children's Research Hospital ยท Tests: Cyclophosphamide, Fludarabine, Mesna, Apheresis, SJCARB7H3_41BBL infusion Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors NCT06500819Phase 11 site๐Ÿ“ Palo Alto Stanford University ยท Tests: B7-H3CART Dose (Intravenous) Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor NCT04616560Phase 232 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Orange National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging, Multigated Acquisition โ€ฆ Tissue Expression of Krรผppel-Like Factors 4 and 7 in Bone Tumors NCT06935864n/a2 sites๐Ÿ“ Cairo๐Ÿ“ Cairo Ain Shams University ยท Tests: KLF factor (4 and 7) Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors NCT04851119Phase 1, Phase 221 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Orange Children's Oncology Group ยท Tests: Biospecimen Collection, Dual X-ray Absorptiometry, Tegavivint, X-Ray Imaging Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors NCT06541262Phase 1, Phase 224 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Oakland Milton S. Hershey Medical Center ยท Tests: Silmitasertib, Irinotecan, Temozolomide, Vincristine Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) NCT07297979Phase 113 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Baltimore Amgen ยท Tests: Xaluritamig Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies NCT04308330Phase 11 site๐Ÿ“ Valhalla New York Medical College ยท Tests: Vorinostat
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy